Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- Eisai Subscribes to Incyte Genomics"Databases
April 23, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
April 23, 2001
- Mochida, Maruishi to Jointly Develop Capsaicin-based Cream
April 23, 2001
- Lilly's Gemzar Approved for Pancreatic Cancer Treatment
April 23, 2001
- Pharmacia's Zyvox Approved
April 23, 2001
- First Int'l GL for COPD Published
April 23, 2001
- GSK Obtains Import Approval for Alkeran for Injection 50mg
April 23, 2001
- Most Doctors Expect Effective Drugs Will Be Needed for AIDS in 2001: JHSF Survey
April 23, 2001
- Hisamitsu Forms Genofunctionfor Genome-related Business
April 23, 2001
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
April 23, 2001
- Keidanren, Nikkeiren to Discuss Healthcare System for Elderly
April 23, 2001
- WORLD NEWS IN BRIEF
April 23, 2001
- BUSINESS NEWS IN BRIEF -1-
April 23, 2001
- Hac Kimisawa to Open Record-high Number of New Stores
April 23, 2001
- BUSINESS NEWS IN BRIEF -2-
April 23, 2001
- Ain Pharmaciez, Nice Drug to Jointly Operate Large Dispensing Pharmacies in Tokai
April 23, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF
April 23, 2001
- DIAGNOSTICS NEWS IN BRIEF
April 23, 2001
- NEW PRODUCTS NEWS IN BRIEF
April 23, 2001
- Kureha, Sankyo Tie Up for Joint Development of CXCR4 Blocker
April 23, 2001
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…